Research Overview: WINIMED 10 Laboratory Standard
WINIMED 10 by Deus Medical is a pharmaceutical-grade stanozolol formulation designed exclusively for in-vitro laboratory research applications. This synthetic anabolic compound enables researchers to investigate the molecular mechanisms of protein synthesis modulation and anabolic pathway regulation in controlled laboratory environments. The standardised 10mg formulation provides consistent dosing parameters for experimental protocols examining steroid receptor interactions and cellular response mechanisms.
Researchers studying metabolic pathways can examine how stanozolol influences nitrogen retention mechanisms and protein synthesis cascades at the cellular level. The compound’s unique molecular structure allows for detailed analysis of androgen receptor binding affinity and downstream signaling pathway activation. Laboratory investigations frequently focus on understanding the compound’s effects on collagen synthesis and tissue remodeling processes.
Scientific Research Applications
Laboratory studies utilise WINIMED 10 to investigate anabolic mechanisms in tissue culture systems and cellular models. Researchers examine the compound’s interaction with androgen receptors and subsequent transcriptional changes in target genes. The standardised formulation enables reproducible experimental conditions for studying protein synthesis enhancement and nitrogen balance alterations in controlled laboratory settings.
Advanced research applications include investigating the compound’s effects on hepatic metabolism and lipid profile modifications through Stroid UK Shop. Studies examining the molecular basis of performance enhancement mechanisms frequently utilise this compound alongside other research materials from specialised stanozolol research collections. Comparative studies often integrate findings with research conducted using selective androgen receptor modulators and peptide research compounds to understand broader anabolic signaling networks.
Technical Specifications
| Active Compound | Stanozolol |
|---|---|
| Concentration | 10mg per unit |
| Manufacturer | Deus Medical |
| Molecular Formula | C21H32N2O |
| Molecular Weight | 328.49 g/mol |
| CAS Number | 10418-03-8 |
| Storage Conditions | Store below 25°C, protect from light |
| Presentation | Oral tablets |
Research Compliance Statement
WINIMED 10 is supplied strictly for laboratory research purposes and in-vitro studies only. This product is not intended for human consumption, therapeutic use, or any application involving direct human contact. Researchers must ensure compliance with all applicable regulations governing the use of research chemicals in their jurisdiction. Proper laboratory safety protocols and appropriate waste disposal procedures must be followed when handling this research compound.
